183 related articles for article (PubMed ID: 21690596)
1. Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review.
Booth RA; Ansari MT; Loit E; Tricco AC; Weeks L; Doucette S; Skidmore B; Sears M; Sy R; Karsh J
Ann Intern Med; 2011 Jun; 154(12):814-23, W-295-8. PubMed ID: 21690596
[TBL] [Abstract][Full Text] [Related]
2. Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs.
Booth RA; Ansari MT; Tricco AC; Loit E; Weeks L; Doucette S; Skidmore B; Hoch JS; Tsouros S; Sears M; Sy R; Karsh J; Mani S; Galipeau J; Yurkiewich A; Daniel R; Tsertsvadze A; Yazdi F
Evid Rep Technol Assess (Full Rep); 2010 Dec; (196):1-282. PubMed ID: 23126559
[TBL] [Abstract][Full Text] [Related]
3. Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?
Higgs JE; Payne K; Roberts C; Newman WG
Pharmacogenomics; 2010 Feb; 11(2):177-88. PubMed ID: 20136357
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.
Ford LT; Berg JD
J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Clin Pharmacol; 2004 Mar; 60(1):5-10. PubMed ID: 14985890
[TBL] [Abstract][Full Text] [Related]
6. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
7. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
[TBL] [Abstract][Full Text] [Related]
8. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease.
Gazouli M; Pachoula I; Panayotou I; Chouliaras G; Anagnou NP; Chroussos G; Roma E
Ann Gastroenterol; 2012; 25(3):249-253. PubMed ID: 24714152
[TBL] [Abstract][Full Text] [Related]
10. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
11. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
12. Reducing risk in thiopurine therapy.
Marinaki AM; Arenas-Hernandez M
Xenobiotica; 2020 Jan; 50(1):101-109. PubMed ID: 31682552
[TBL] [Abstract][Full Text] [Related]
13. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
14. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
15. Pre-analytic and analytic sources of variations in thiopurine methyltransferase activity measurement in patients prescribed thiopurine-based drugs: A systematic review.
Loit E; Tricco AC; Tsouros S; Sears M; Ansari MT; Booth RA
Clin Biochem; 2011 Jul; 44(10-11):751-7. PubMed ID: 21402061
[TBL] [Abstract][Full Text] [Related]
16. Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy.
Cabaleiro T; Roman M; Gisbert JP; Abad-Santos F
Curr Drug Metab; 2012 Nov; 13(9):1277-93. PubMed ID: 22493988
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies.
Donnan JR; Ungar WJ; Mathews M; Rahman P
Ther Drug Monit; 2011 Apr; 33(2):192-9. PubMed ID: 21240057
[TBL] [Abstract][Full Text] [Related]
19. Whole-Blood Thiopurine S-Methyltransferase Genotype and Phenotype Concordance in Iranian Kurdish Ulcerative Colitis (UC) Patients.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Bashiri H; Zobeiri M; Tanhapour M; Pourmotabbed T
Clin Lab; 2017 May; 63(5):947-954. PubMed ID: 28627831
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
